Candriam S.C.A. - NEWLINK GENETICS CORP ownership

NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 88 filers reported holding NEWLINK GENETICS CORP in Q4 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of NEWLINK GENETICS CORP
ValueSharesWeighting
Q3 2018$593,000
-57.5%
248,000
-15.4%
0.01%
-63.6%
Q2 2018$1,395,000
-34.3%
293,0000.0%0.02%
-38.9%
Q1 2018$2,124,000
-10.6%
293,0000.0%0.04%
-12.2%
Q4 2017$2,376,000
-28.8%
293,000
-10.7%
0.04%
-29.3%
Q3 2017$3,339,000
+506.0%
328,000
+337.3%
0.06%
+480.0%
Q2 2017$551,000
+114.4%
75,000
+200.0%
0.01%
+66.7%
Q4 2016$257,000
-85.1%
25,000
-35.9%
0.01%
-83.3%
Q2 2015$1,727,000
-68.4%
39,000
-61.0%
0.04%
-67.3%
Q1 2015$5,472,000
-23.5%
100,000
-44.4%
0.11%
-26.7%
Q4 2014$7,155,000180,0000.15%
Other shareholders
NEWLINK GENETICS CORP shareholders Q4 2018
NameSharesValueWeighting ↓
FT Options LLC 21,900$1,292,0001.11%
TIVERTON ASSET MANAGEMENT LLC 288,807$18,215,0000.77%
Knoll Capital Management, LLC 102,437$1,153,0000.37%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 460,146$5,181,0000.36%
WALL STREET ASSOCIATES 79,000$890,0000.36%
Endurant Capital Management LP 62,491$704,0000.24%
FT Options LLC 21,903$247,0000.21%
Virtus ETF Advisers LLC 24,463$275,0000.20%
Orbimed Advisors 1,581,506$17,808,0000.19%
HAP Trading, LLC 227,728$2,564,0000.15%
View complete list of NEWLINK GENETICS CORP shareholders